Suchergebnisse - "Huri, Hasniza Zaman"

PubPharm (59)

31

Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings

enthalten in: Therapeutics and clinical risk management | 2019

von Elnaem, M. | Mohamed, M. | Huri, H. | +1

32

Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes : Quasi-experimental design

enthalten in: PloS one | 2019

von Elnaem, M. | Nik Mohamed, M. | Huri, H.

33

The Use of Antidepressants for Physical and Psychological Symptoms in Cancer

enthalten in: Current drug targets | 2018

von Zaini, S. | Guan, N. | Sulaiman, A. | +3

34

The Use of Antidepressants for Physical and Psychological Symptoms in Cancer

enthalten in: Current drug targets | 2018

von Zaini, S. | Guan, N. | Sulaiman, A. | +3

35

Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance

enthalten in: Clinical biochemistry | 2017

von Ahmed, R. | Huri, H. | Muniandy, S. | +4

36

Statin Therapy Prescribing for Patients with Type 2 Diabetes Mellitus : A Review of Current Evidence and Challenges

enthalten in: Journal of pharmacy & bioallied sciences | 2017

von Elnaem, M. | Mohamed, M. | Huri, H. | +2

37

Drug-related problems in patients with erectile dysfunctions and multiple comorbidities

enthalten in: Therapeutics and clinical risk management | 2017

von Huri, H. | Ling, C. | Razack, A.

38

Chemokine Like Receptor-1 (CMKLR-1) Receptor : A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer

enthalten in: Current pharmaceutical design | 2017

von Perumalsamy, S. | Aqilah Mohd Zin, N. | Widodo, R. | +3

39

Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer

enthalten in: Current pharmaceutical design | 2017

von Perumalsamy, S. | Aqilah Mohd Zin, N. | Widodo, R. | +3

40

Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes mellitus

enthalten in: Pharmacogenomics | 2016

von Jamaluddin, J. | Huri, H. | Vethakkan, S.